Explore 3 Stock Ideas & Industry Insights Download Free Report

News

bioAffinity Technologies to Present CyPath Lung Posters at 2026 NAVREF Conference

bioAffinity Technologies, Inc. filed a Form 8-K on September 22, 2026, disclosing that the company issued a press release announcing the presentation of two posters on its CyPath® Lung diagnostic at the 2026 NAVREF Annual Conference, scheduled for September 27-30, 2026, in Arlington, Virginia.

Aditi Sarkar | 22 September 2026

Columbus McKinnon Reprices Term Loan B, Cuts Margin by 0.50%

Columbus McKinnon Corporation filed a current report on Form 8-K on September 22, 2026, disclosing that it entered into a First Amendment to its Credit Agreement on September 21, 2026, refinancing its Term Loan B Facility and reducing the applicable interest rate margin on …

Anjali Anand | 22 September 2026

iPower Stockholders Approve Stock Split and Equity Plan

iPower Inc. filed a Form 8-K on September 22, 2026, disclosing the voting results from a special meeting of stockholders held on September 21, 2026, at which shareholders approved three proposals covering a stock offering authorization, a reverse stock split, and an amended equity …

Aakashdeep | 22 September 2026

Upbound Group Names Scott Young as Chief Operating Officer

Upbound Group, Inc. filed an 8-K with the SEC on September 22, 2026, disclosing the appointment of Scott Young as Executive Vice President and Chief Operating Officer, effective the same date.

Shwetambri Chauhan | 22 September 2026

Madison Square Garden Sports Corp. Names New Chief Legal Officer

Madison Square Garden Sports Corp. filed an 8-K on September 22, 2026, disclosing executive officer changes effective September 21, 2026, including the appointment of Jamaal T. Lesane as Executive Vice President and Chief Legal Officer.

Shwetambri Chauhan | 22 September 2026

Lucid Diagnostics Reports Payment Pathway Advances for EsoGuard

Lucid Diagnostics Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing that it issued a press release announcing advances in payment, billing, and coding pathways for its EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device.

Anjali Anand | 22 September 2026

Caesars Entertainment Supplements Merger Proxy After Stockholder Demand

Caesars Entertainment, Inc. filed an 8-K on September 22, 2026, reporting that it received a stockholder demand letter on September 15, 2026, and voluntarily supplemented its definitive proxy statement to address allegations concerning its outside legal counsel's concurrent representations.

Vinay Lochav | 22 September 2026

Piper Sandler Elects Wendy Schoppert to Board of Directors

Piper Sandler Companies filed a Form 8-K on September 22, 2026, disclosing the election of Wendy L. Schoppert to its Board of Directors, effective that same date.

Aakashdeep | 22 September 2026

Brand Engagement Network Closes $1.05M Private Placement

Brand Engagement Network Inc. filed a Form 8-K on September 22, 2026, disclosing that it entered into a Securities Purchase Agreement on September 21, 2026, for a private placement of common stock and warrants generating total gross proceeds of $1,051,025.00.

Nitish Kishor | 22 September 2026

Nuburu Files Amended Quarterly Report With Restatement

Nuburu, Inc. filed an amended quarterly report on Form 10-Q/A on September 22, 2026, restating its financial statements for the three and six months ended June 30, 2026, to correct a misstatement related to the fair value calculation of the Tekne Convertible Note Receivable.

Aakashdeep | 22 September 2026
Support

Hi! How can we help you today?

Loading…